To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

Welcome to JPT

Your Cart
US$0.00

Press releases & news

Please have a look at our recent news or browse the archive.

Press releases & news

The US Biosecure Act - JPT is not affected!

Mpox and Vaccinia Virus Peptide Tools for Immune Response Monitoring

Studying HPV Infections & Cancer: JPT updated its PepMix Peptide Catalog!

Introducing Our New 10mg Antigen Peptides!

Dengue Fever on the Rise: Explore JPT's Dengue Peptide Tools

NEW PepMix Peptide Pools: Lassa, Chikungunya, Rabies and more!

20 Years of Excellence in Large Scale Peptide Synthesis – Get Started Today!

Explore the Spectrum of Peptide Modifications with JPT!

JPT's Peptide Synthesis: Where Precision Meets Customization

JPT is now CIR certified in France - Get a tax credit on our products!

NEW: Monkeypox & Vaccinia Peptide Pools & Microarrays!

NEW: PepMix Collections for SARS-CoV-2 Wuhan & Variants

Our Peptides in Action: Recent Publications in Oncology!

We will be at the annual FOCIS in San Francisco!

Recent Publications on Infectious Diseases

Check Out Our New Fully Purified Omicron Pools!

Our new US-based peptide contact – Aude-Marie Alem

The Largest Variety of Custom Peptide Formats

Join us at CIMT in Mainz & ISCT in San Francisco 2022!

Study Cross-reactivity & COVID-19 Vaccine Responses!

JPT Maintains Quality Leadership - ISO 9001:2015 Recertification

Let our Antibody Profiling Assays Work for You!

NEW: PepMixes for Omicron BA.2 Spike & RBD

Improve Your Phosphoproteomic Assays

Identify Epitope-resolved Antibody Responses with Peptide Microarrays

Introducing JPT PepMix™ Pan Select Peptide Pools – the smartest approach to broad antigen-specific T-cell stimulation with single peptide pools

NEW: PepMix™ & PepStar™ for Adenovirus Proteins available

NEW: Omicron & Lambda PepMix™ & PepStar™

Happy New Year! Our Highlights 2021 are...

New AppNote Available: SARS-CoV-2 cross-reactivity upon infection & vaccination

JPT’s peptides continue to contribute to important SARS-CoV-2 publications

JPT Launches a New Website!

NEW: Delta & Kappa SARS-CoV-2 PepMixes™

NEW: SARS-CoV-2 PepMixes™ for Brazil, South Africa & California Mutations

NEW: Virus-spanning PepMix™ Select Epitope Pools from JPT

Identify Epitope Resolved Antibody Responses with SARS-CoV-2 Peptide Microarrays

NEW Antigen Peptide Pools: SARS-CoV-2 B.1.1.7 (UK) & HCoV NCAP PepMixes™

Have a Healthy New Year! 5 Things we are grateful for

13 NEW Standardization Kits for MS based Neo-epitope Identification

Study SARS CoV-2 Cross-Reactivity with MERS, SARS & Seasonal Coronaviruses

What’s new in Neo-Epitope Discovery & Therapy?

Infectious diseases beyond COVID-19 – JPT’s peptide formats in the literature

Everything You Need to Know about Peptides

JPT’s SARS CoV-2 Products Deliver Meaningful Results!

SARS-COV-2 Spike & NCAP Mutations as PepMix™ Peptide Pools

Study SARS CoV-2 Cross Reactive T-Cells with EMPS-Peptides from Endemic HCoV’s

SARS COV-2 Mass Spec Reference Kit Released!

JPT’s Innovation Featured on Cover of Proteomics Journal

Mission Completed! Purified SARS-CoV-2 PepMixes™ & Peptide Arrays

NEW: Additional SARS-CoV-2 PepMixes™ & Antigen Peptides

New! SARS-CoV-2 Spike & NCAP Epitope Mapping Peptide Sets

COVID-19: JPT receives status as Systemically Important Company

NEW! SARS-CoV-2 PepMix™ Peptide Pools & Microarrays

Measure T-Cell Clone Specificity with PepMaster™

Peptide Pool Concepts from Discovery to the Clinic

JPT Supports Immudex’ Annual Elispot Proficiency Panel 2020

Our Highlights in 2019

30 Years After The Wall: Eastern German Success Stories

Boost Peptide Reliability with Peptide Analysis Services

Have a look at Proteomics Publications using SpikeTides™ & Co.

Are you going to FOCiS or BIO?

Meet us at AAI, CIMT, Brisbane Immunotherapy & ISCT!

NEW Cell Activation Kit: PepSup™

JPT Maintains Quality Leadership - ISO 9001:2015 Recertification

Free ELISPOT Workshops in Belgium & The Netherlands

Superior Positive Control Pools for Better T-Cell Assays

JPT launches The Human Proteome Peptide Catalog

A New Peptide Approach to meet Antigen Sequence Diversity

PROCAL - a new RT Standardization Kit for LC-MS based Proteomics

TheraCode GmbH acquires JPT Peptide Technologies